However, the combination of cGAMP and OXA can jointly inhibit the PI3K/AKT signaling pathway, play a synergistic role in increasing p53 expression, significantly increase the sensitivity of OXA to tumor cells, and effectively reverse OXA drug resistance. This evidence concerns the gene AKT1 and neoplasm.